HEALTH CARE DEVICE AND HEALTH CARE METHOD

Abstract

A health care device illustrated has a low-frequency wave emitter, a low-frequency waveguide and a plant essential oil carrier disposed between the low-frequency wave emitter and the low-frequency waveguide. The low-frequency wave emitter emits a low-frequency wave with a predetermined frequency, and the low-frequency wave firstly passes through the plant essential oil carrier, and then propagates to the low-frequency waveguide. Next, energy of the low-frequency wave is focused in the low-frequency waveguide, and then the low-frequency wave is emitted out from the low-frequency waveguide. A health care method illustrated emits the low-frequency wave with the predetermined frequency to a belly button of a user by using the health care device. The health care device and method increase contents of NAD.sup.+ in blood of the user, and achieve effects of convenient operation, accurate use position identification, and non-invasive and non-contact health care.

Claims

1. A health care device, at least comprising: a low-frequency wave emitter, configured to emit a low-frequency wave with a predetermined frequency; a low-frequency waveguide; and a plant essential oil carrier, disposed between the low-frequency wave emitter and the low-frequency waveguide; wherein the low-frequency wave firstly passes through the plant essential oil carrier and then propagates to the low-frequency waveguide, and next, energy of the low-frequency wave is focused in the low-frequency waveguide, and then the low-frequency wave is emitted out from the low-frequency waveguide.

2. The health care device of claim 1, wherein the plant essential oil carrier comprises a plant essential oil.

3. The health care device of claim 2, wherein the plant essential oil carrier is a part of a plant that contains the plant essential oil, or the plant essential oil is loaded in a container, or the plant essential oil is adsorbed on an adsorbed substance.

4. The health care device of claim 3, wherein the predetermined frequency is 1.27 Hz to 1.81 Hz.

5. The health care device of claim 4, wherein the low-frequency waveguide comprises a column part and/or a pyramid part, and the column part or the pyramid part is formed with an accommodating space therein, and the accommodating space accommodates the plant essential oil carrier.

6. The health care device of claim 5, wherein the health care device is installed on a frame, and located at a predetermined location in front of a belly button of a user with a predetermined distance, and the predetermined distance is 5 cm to 8 cm.

7. The health care device of claim 5, wherein the low-frequency waveguide is located at the predetermined location.

8. The health care device of claim 7, wherein after the energy of the low-frequency wave is focused in the low-frequency waveguide and then is emitted out from the low-frequency waveguide, the low-frequency wave propagates toward the belly button, and then reaches the belly button.

9. A health care method, comprising: using a health care device located at located at a predetermined location in front of a belly button of a user with a predetermined distance to emit a low-frequency wave with a predetermined frequency, wherein the predetermined distance is 5 cm to 8 cm, and the health care device comprises: a low-frequency wave emitter, configured to emit the low-frequency wave; a low-frequency waveguide; and a plant essential oil carrier, disposed between the low-frequency wave emitter and the low-frequency waveguide; wherein the low-frequency wave firstly passes through the plant essential oil carrier and then propagates to the low-frequency waveguide, and next, energy of the low-frequency wave is focused in the low-frequency waveguide, and then the low-frequency wave is emitted out from the low-frequency waveguide.

10. The health care method of claim 9, wherein the predetermined frequency is 1.27 Hz to 1.81 Hz.

11. The health care method of claim 10, wherein the predetermined frequency is 1.45 Hz.

12. The health care method of claim 9, wherein the plant essential oil carrier comprises a plant essential oil.

13. The health care method of claim 12, wherein the plant essential oil carrier is a part of a plant that contains the plant essential oil, or the plant essential oil is loaded in a container, or the plant essential oil is adsorbed on an adsorbed substance.

14. The health care method of claim 10, wherein the low-frequency waveguide comprises a column part and/or a pyramid part, and the column part or the pyramid part is formed with an accommodating space therein, and the accommodating space accommodates the plant essential oil carrier.

15. The health care method of claim 9, wherein the low-frequency waveguide is located at the predetermined location.

16. The health care method of claim 9, wherein after the energy of the low-frequency wave is focused in the low-frequency waveguide, and then the low-frequency wave is emitted out from the low-frequency waveguide, the low-frequency wave propagates toward the belly button, and then reaches the belly button.

Description

BRIEF DESCRIPTIONS OF DRAWINGS

[0029] The accompanying drawings are included to provide a further understanding of the present disclosure and are incorporated in and constitute a part of this specification. The drawings illustrate exemplary embodiments of the present disclosure and, together with the description, which are used to explain the principles of the present disclosure.

[0030] FIG. 1 is a schematic diagram of executing a health care method according to an embodiment of the present disclosure.

[0031] FIG. 2 is a schematic diagram showing a structure of a health care device when executing a health care method according to an embodiment of the present disclosure.

[0032] FIG. 3 is a schematic diagram showing a structure of a health care device according to an embodiment of the present disclosure.

[0033] FIG. 4 is a schematic diagram showing a structure of a health care device with a tube according to an embodiment of the present disclosure.

[0034] FIG. 5 is a schematic diagram showing a structure of a health care device with a vertically standing rod according to an embodiment of the present disclosure.

[0035] FIG. 6 is a schematic diagram showing a structure of a health care device installed on or in a frame according to an embodiment of the present disclosure.

[0036] FIG. 7 is a schematic diagram showing a structure that a low-frequency wave emitter of a health care device is installed on a bottom surface of a pyramid part according to an embodiment of the present disclosure.

DETAILS OF EMBODIMENTS

[0037] To understand the technical features, content and advantages of the present disclosure and its efficacy, the present disclosure will be described in detail with reference to the accompanying drawings. The drawings are for illustrative and auxiliary purposes only and may not necessarily be the true scale and precise configuration of the present disclosure. Therefore, the scope of the present disclosure should not be limited to the scale and configuration of the attached drawings.

[0038] Refer to FIG. 1, the present disclosure provides a health care method. The method arranges a low-frequency wave emitter 2 at a predetermined location P in front of a belly button 11 of a user 1 with a predetermined distance D and makes the low-frequency wave emitter 2 emit a low-frequency wave W with a predetermined frequency toward the belly button 11 of the user 1. The aforementioned front refers to the front of a human body in a direction of a human abdomen, and correspondingly, the back refers to the back of the human body. The predetermined location P is located on a virtual bottom surface S2 of a virtual pyramid S, and the belly button 11 is a virtual vertex S1 of the virtual pyramid S. The predetermined distance D is designed to be not larger than 8 cm, or the predetermined distance D is designed to be not less than 5 cm, or the predetermined distance D is designed to be within a range between 5 cm and 8 cm (p.s. the range comprises two end values of 5 cm and 8 cm). Preferably, the predetermined location P is located on the center of the virtual bottom surface S2, for example, the virtual pyramid S is a circular cone, the predetermined location P is located on the circular center of the virtual bottom surface S2 being a circle surface, and the predetermined distance D is the distance between circular center and the belly button 11, which is within the range between 5 cm and 8 cm. A plant essential oil carrier A is disposed between the predetermined position P and the virtual vertex S1. The plant essential oil carrier A comprises a plant essential oil, and the plant essential oil refers to the volatile oily substance at room temperature, which can be stored in plants or obtained by plants, so the plant essential oil carrier A can be a part containing the plant essential oil, and the part t containing plant essential oil may be a root, a stem, a leave, a flower, a fruit and a seed, for example the leave of plectranthus amboinicus. The plant essential oil carrier A can also be that the plant essential oil obtained by various plants through known distillation or extraction is loaded in a container, or adsorbed on an adsorbate such as cotton or paper. The plant essential oil can be at least one of tea tree oil, bitter refining oil, left-hand sesame oil, lemon oil, oil of wintergreen, camphor tree oil, clove oil, peppermint oil, eucalyptus oil, citronella oil, chrysanthemum oil, clary sage oil, eucalyptus oil, rose oil, jasmine oil, geranium oil, rose geranium oil, ylang-ylang oil, frankincense oil, patchouli oil, rosemary oil, helichrysum oil, thyme oil, pine oil, cedar oil, juniper oil, sandalwood oil, basil oil, lime oil, tangerine oil, sweet orange oil, petitgrain oil, petitgrain oil, neroli oil, citrus oil, litsea pepper oil, hyssop oil, melaleuca oil or ginger oil. The low-frequency wave W propagating toward the belly button 11 firstly passes through the plant essential oil carrier A and then reaches the belly button 11.

[0039] The low-frequency wave emitter 2 is preferably an infrasonic transducer, and the low-frequency wave W can be the infrasonic. The structure of the infrasonic transducer comprises a power supply 21 and a vibration part 22. The vibration part 22 is electrically connected to the power supply 21. The vibration part 22 is a disc-shaped piezoelectric ceramic transducer. The piezoelectric ceramic transducer is made of piezoelectric material polarized in the thickness direction. The power supply 21 provides power to the vibration part 22 to make the vibration part 22 vibrates in the thickness direction to generate the infrasonic with the predetermined frequency. In the present disclosure, the predetermined frequency is not larger than 1.81 Hz, or the predetermined frequency is not less than 1.27 Hz, or the predetermined frequency is within a range between 1.27 Hz and 1.81 Hz (p.s. the range comprises two end values of 1.27 Hz and 1.8 Hz). Preferably, the predetermined frequency is 1.45 Hz.

[0040] In other words, the present disclosure also provides a health care device, the health care device is arranged at a predetermined location P in front of the belly button 11 of the user with a predetermined distance D. The health care device at least comprises a low-frequency wave emitter 2.

Detection Manner and Effect of Experiment 1

[0041] In Embodiment 1 of the following TABLE 1, the health care method is executed to personnel A1 and personnel A2, the predetermined distance D is selected to be 5 cm, the predetermined frequency is selected to be 1.45 Hz, and the low-frequency wave is selected to be the infrasonic. The personnel A1 is a 74-years old man, the personnel A2 is a 72-years old woman. Before executing the health care method, blood samples are drawn from the personnel A1 and personnel A2 and sent to the medical laboratory for immunological examination to check the percentage (i.e., content) of the active T cells. On the 19-th day after the execution of the health care method for 2 hours, the blood sample of the personnel A1 is again taken and sent to the medical laboratory for immunological examination, and on the 42-nd day after the execution of the health care method for 2 hours, the blood sample of the personnel A2 is also taken again and sent to the medical laboratory for immunological examination. The percentages of the active T cells of the blood samples are examined in the same way, and the results are recorded in TABLE 1 which is described later. In TABLE 1, the difference between Embodiment 1 and Comparative Example 1 is that the plant essential oil carrier A is not used in Comparative Example 1.

TABLE-US-00001 TABLE 1 PERSONNEL A1 PERSONNEL A2 CHANGE RATE = CHANGE RATE = CONTENT OF CONTENT OF ACTIVE T CELLS ACTIVE T CELLS AFTER EXECUTION/ AFTER EXECUTION/ CONTENT OF CONTENT OF CONTENT OF BEFORE AFTER ACTIVE T CELLS BEFORE AFTER ACTIVE T CELLS ACTIVE T CELLS EXECUTION EXECUTION BEFORE EXECUTION EXECUTION EXECUTION BEFORE EXECUTION COMPARARTIVE 6.2% 12.8% 206.5% 5.3% 7.9% 149% EXAMPLE 1 EMBODIMENT 1 13.5% 31.7% 234.8% 8.1% 14.6% 180%

[0042] From TABLE 1, in Comparative Example 1 without using the plant essential oil carrier, the content change rate of the active T cells in personnel A1 is 206.5%, and in Embodiment 1 which the plant essential oil carrier is used, the content change rate of the active T cells in personnel A1 is 234.8%. That is, while the plant essential oil carrier is used in the health care method, the content of the active T cells in personnel A1 can further increase 28.3%. In Comparative Example 1 without using the plant essential oil carrier, the content change rate of the active T cells in personnel A2 is 149%, and in Embodiment 1 which the plant essential oil carrier is used, the content change rate of the active T cells in personnel A2 is 180%. That is, while the plant essential oil carrier is used in the health care method, the content of the active T cells in personnel A2 can further increase 31%. Apparently, the health care method of the present disclosure is highly effective and can maintain long-term health effects.

Detection Manner and Effect of Experiment 2

[0043] In Embodiments 2, 3, 4 and 5 of the following TABLE 2, the health care method is executed to the personnels A3, A4, A5 and A6, the predetermined distance D is selected to be 5 cm, the predetermined frequency is selected to be 1.45 Hz, and the low-frequency wave is selected to be the infrasonic. The personnel A3 is a 67-years old man, the personnel A4 is a 64-years old man, the personnel A5 is a 75-years old woman, and the personnel A6 is a 47-years old woman. Before executing the health care method, blood samples are drawn from personnels A3 to A6 and sent to the medical laboratory for immunological examination to check the concentrations of NAD.sup.+, wherein the unit of the concentration of NAD.sup.+ is nanomoles per liter (nmol/L). On the 19-th day after the execution of the health care method for 2 hours, the blood samples of personnels A3 to A6 are again taken and sent to the medical laboratory for immunological examination, the concentrations of NAD.sup.+ of the blood samples are examined in the same way, and the results are recorded in TABLE 2 which is described later.

TABLE-US-00002 TABLE 2 CONCENTRATIONS Personnel Personnel Personnel Personnel OF NAD.sup.+ (nmol/L) A3 A4 A5 A6 BEFORE 43 26 23 32 EXECUTION AFTER 116 64 42 53 EXECUTION Change Rate = Concentration After 270% 246% 183% 166% Execution/ Concentration Before Execution

[0044] From TABLE 2, it can be known the concentration of NAD.sup.+ of personnel A3 before the health care method is executed is 43 nmol/L, the concentration of NAD.sup.+ of personnel A3 after the health care method is executed is 116 nmol/L, and the concentration change rate of personnel A3 is 270%, that is, the concentration of NAD.sup.+ of personnel A3 is increased 170%. Similarly, the concentration of NAD.sup.+ of personnel A4 before the health care method is executed is 26 nmol/L, the concentration of NAD.sup.+ of personnel A4 after the health care method is executed is 64 nmol/L, and the concentration change rate of personnel A4 is 246%, that is, the concentration of NAD.sup.+ of personnel A4 is increased 146%. The concentration of NAD.sup.+ of personnel A5 before the health care method is executed is 26 nmol/L, the concentration of NAD.sup.+ of personnel A5 after the health care method is executed is 42 nmol/L, and the concentration change rate of personnel A5 is 183%, that is, the concentration of NAD.sup.+ of personnel A5 is increased 83%. The concentration of NAD.sup.+ of personnel A6 before the health care method is executed is 32 nmol/L, the concentration of NAD.sup.+ of personnel A6 after the health care method is executed is 53 nmol/L, and the concentration change rate of personnel A6 is 166%, that is, the concentration of NAD.sup.+ of personnel A6 is increased 66%. Therefore, the health care method provided by the present disclosure can promote the increase of NAD.sup.+ concentration, and it can increase the NAD.sup.+ concentration as long as it is performed once for 2 hours. Obviously, the health care method of the present disclosure is highly effective and can maintain long-term health care effects.

[0045] Refer to FIG. 2 and FIG. 3, the present disclosure further provides a health care device 100 for executing the above health care method. The health care device 100 comprises the low-frequency wave emitter 2, a column part 3 and a pyramid part 4. The column part 3 is preferably the circular column, the column part 3 has a top surface 31, a bottom surface 32 and a body 33, and the two ends of the body 33 of the column part 3 are respectively connected to the top surface 31 of column part 3 and the bottom surface 32 of column part 3. The column body 33 is provided with an accommodating space 331 recessed from the bottom surface 32 to the top surface 31, and the accommodating space 331 is provided with the plant essential oil carrier A. The pyramid part 4 has a vertex 40, a bottom surface 41 and a body 42, wherein two ends of the body 42 of the pyramid part 4 are respectively connected to the vertex 40 and the bottom surface 41 of the pyramid part 4. The top surface 31 of the column part 3 is correspondingly joined with the bottom surface 41 of the pyramid part 4, for example, by welding or screwing. Preferably, the column part 3 and the pyramid part 4 are respectively metal column and metal pyramid, respectively. More preferably, the column part 3 and the pyramid part 4 are formed integrally, in other words, the top surface 31 of the column part 3, the body 33 of the column part 3, the body 42 of the pyramid part 4 and the vertex 40 of the pyramid part 4 are formed integrally, i.e., the column part 3 and the pyramid part 4 are one-piece part. It is noted that the low-frequency waveguide is formed by combining the column part 3 and the pyramid part 4.

[0046] The low-frequency wave emitter 2 is connected with the bottom surface 32 of the column part 3, preferably this low-frequency wave emitter 2 is directly connected with the bottom surface 32 of the column part 3, such as this low-frequency wave emitter 2 is welded or screwed to the bottom surface 32 of the column part 3, so when the power supply 21 is activated, the vibration part 22 will generate the low-frequency wave W of the predetermined frequency (please refer to FIG. 1 again). Next, the low-frequency wave W is transmitted to this bottom surface 32 of column part 3 and passes through the plant essential oil carrier A, and then the body 33 of the column part 3 is used to transmit the low-frequency wave W sequentially to the bottom surface 41 of the pyramid part 4 and this vertex 40. By using the structure of the pyramid part 4 which the bottom surface 41 of the pyramid part 4 is designed to be wider than and tapered to the vertex 40, the energy of the low-frequency wave W is more concentrated as it is transmitted toward the vertex 40. Therefore, when the low-frequency wave W is delivered to this vertex 40, the energy of the low-frequency wave W is gathered to the maximum, and then emitted toward the belly button 11 from the vertex 40. The vertex 40 of the pyramid part 4 is a tip, and therefore, based on the principle of the tip discharge in electricity, the low-frequency wave W can be concentrated on the vertex 40 to be released and emitted toward the belly button 11. It is noted that, the vertex 40 is located at the predetermined location P at this time.

[0047] Refer to FIG. 4, and in another one embodiment, the low-frequency wave emitter 2 is connected to the bottom surface 32 and the accommodating space 331 of the column part 3 via a tube 5. The low-frequency wave W is transmitted to the bottom surface 32 and the accommodating space 331 of the column part 3 via the tube 5. The low-frequency wave W passes through the plant essential oil carrier A, and then passes to the vertex 40 to propagates toward and reaches the belly button 11 as previously described. With the arrangement of the tube 5, the power supply 21 and/or the vibration part 22 of the low-frequency wave emitter 2 can be kept away from the human body, to avoid interference with any electronic device which has implanted in the human body.

[0048] Refer to FIG. 5, and in another one embodiment, the vertex 40 further has a rod 401 being vertically standing and having a longitudinal direction away from the bottom surface 41 of the pyramid part 4. Preferably, the rod 401 is a metal rod such as metal silk or metal wire. The longitudinal direction of the rod 401 is coincided with a normal line N of the center C on the bottom surface 41 of the pyramid part 4, and the normal line N of the center C on the bottom surface 41 of the pyramid part 4 passes extends toward the belly button 11. Therefore, the energy of the low-frequency wave W can be more directed to concentrate on a tip 402 of the rod 401 to be released and emitted toward the belly button 11. Specifically, the tip 402 is located at the predetermined location P at this time.

[0049] Refer to FIG. 6, in another one embodiment, the health care device 100 is installed in or on a frame 200, the user 1 is lying on the platform (not shown in the drawings), the frame 200 is erected on the platform, and the health care device 100 is located above the belly button of the user 1. In this way, the user 1 can also get a proper rest during the health care process.

[0050] Refer to FIG. 7, in another one embodiment, the health care device 100 can also comprises the low-frequency wave emitter 2 and the pyramid part 4, but the column part 3 is not included in the health care device 100. The body 42 is provided with the accommodating space 331 sunken from the bottom surface 41 toward the vertex 40, and the accommodating space 331 is provided with the plant essential oil carrier A. In particular, at this time, the pyramid part 4 is the low-frequency waveguide and does not include the column part 3. The low-frequency wave emitter 2 is arranged on the bottom surface 41 of pyramid part 4, and the low-frequency wave emitter 2 is connected to the bottom surface 41 of the pyramid part 4. Preferably, the low-frequency wave emitter 2 is directly connected to the bottom surface 41 of pyramid part, for example, the low-frequency wave emitter 2 is adhered, welded or screwed to the bottom surface 41 of the pyramid part 4. Thus, after activating the power supply 21, the vibration part 22 vibrates to generate low-frequency wave W of the predetermined frequency (see FIG. 1 again). Next, the low-frequency wave W is transmitted to the bottom surface 41 of the pyramid part 4, and then passes through plant essential oil carrier A. Next, the low-frequency wave W passes toward the vertex 40 of the pyramid part 4. By using the pyramid design that the diameter is tapered from the bottom surface 41 to the vertex 40 of the pyramid part 4, the energy of the low-frequency wave W is getting concentrated when transmitting to the vertex 40. The pyramid part 4 can be a wooden or metal pyramid, and preferably, the pyramid part 4 is a one-piece wooden pyramid.

[0051] The above-mentioned descriptions represent merely the exemplary embodiment of the present disclosure, without any intention to limit the scope of the present disclosure thereto. Various equivalent changes, alternations or modifications based on the claims of present disclosure are all consequently viewed as being embraced by the scope of the present disclosure.